Flush with cash, Achaogen continues antibiotic work

Xconomy profiles 2009 Fierce 15 winner Achaogen, a South San Francisco-based antibiotics developer that has raised loads of funding from both the government and venture capital investors. In April the developer raised a heft $56 million in Series C financing to support work on its antibiotic pipeline. Antibiotic development has been largely ignored by Big Pharma, but there's a critical need for new drugs to treat bacteria that have become resistant to other medications. The...